ITGAM and plasma cell myeloma: To address whether the myeloma-associated Gr-1+/CD11b+cells had the potential to differentiate into functional osteoclasts that might be responsible for the increased bone lesions associated with MM, we performed in vitro osteoclast differentiation assay.